Castration-Sensitive Prostate Carcinoma: Clinical Trials

2 terminated. 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	2	Terminated 2

Follow Castration-Sensitive Prostate Carcinoma: new trials by email Literature Review of Castration-Sensitive Prostate Carcinoma trials Research Report on Castration-Sensitive Prostate Carcinoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer Antiandrogen Therapy, Abiraterone Acetate, Prednisone - Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone	Phase 2	Terminated	University of Washington	10	2020-06-29	2023-10-26
Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer Abiraterone Acetate, Antiandrogen Therapy, Docetaxel - Castration-Sensitive Prostate Carcinoma, Metastatic Prostatic Adenocarcinoma	Phase 2	Terminated	University of Utah	1	2019-02-08	2020-06-25

Narrower conditions

Prostatic Neoplasms (2)

Broader conditions

Genital Diseases (2)  ·  Genital Diseases, Male (2)  ·  Genital Neoplasms, Male (2)  ·  Male Urogenital Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Prostatic Diseases (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)

Interventions

Abiraterone Acetate (2)  ·  Androgen Antagonists (2)  ·  Prednisone (2)  ·  Docetaxel (1)  ·  Radiation (1)  ·  Radiotherapy (1)  ·  deltacortene (1)  ·  prednylidene (1)

Sponsors

University of Utah (1)  ·  University of Washington (1)

Countries

United States (2)

Top investigators

Benjamin Maughan, MD (1)  ·  Jing Zeng (1)

NIH funding

P50CA097186 (1)